Managing Partner
South San Francisco CA UNITED STATES
Philippe Nore is the Managing Partner of Palo Alto BioVentures, a boutique strategy and business development consulting firm focused on life sciences. He is an experienced consultant, entrepreneur and business executive specialized in clinical diagnostics, life science tools and therapeutics. Before founding Palo Alto Bio Ventures, he co-founded and led as CEO MiNDERA, an innovative MedTech company developing Next-Gen Skin Diagnostics and Analytics. Previously Philippe was Senior International Business Leader at Roche Diagnostics. He was responsible for the development and commercialization of the Ventana Digital Pathology products (hardware, software, algorithms to score assays) in the cancer diagnostics market, including global P&L responsibility. During his tenure at Roche he has successfully launched several FDA-approved products. Prior to that, he was a Senior Engagement Manager at L.E.K. Consulting where he worked with CEOs of small and midsize biotech and life sciences companies. Earlier, he worked at Life Technologies where he headed Strategic Planning and Business Development for the DNA Sequencing business Unit and led the Next-Generation Sequencing taskforce. He also spent 7 years at Bain & Company where he consulted for Fortune 500 companies. Philippe holds a MSc. in chemistry from ESPCI (Paris) and an MBA from the Wharton School where he graduated as a Palmer Scholar.